# Decibel Therapeutics, Inc.

Decibel Therapeutics, Inc. is a company headquartered in Boston, MA, United States.

## Company overview

- **Legal name:** Decibel Therapeutics, Inc.
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Boston, MA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001656536

## About

Decibel Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001656536, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2023-03-14, it reported net income of USD -63,005,000; total assets of USD 123,373,000 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2022 (period ended 2022-12-31)

- **Net income:** -$63.0M (USD -63,005,000)
- **Total assets:** $123.4M (USD 123,373,000)
- **Cash and equivalents:** $34.6M (USD 34,607,000)
- **Operating cash flow:** -$56.9M (USD -56,898,000)

### FY2021 (period ended 2021-12-31)

- **Net income:** -$51.8M (USD -51,823,000)
- **Total assets:** $184.5M (USD 184,477,000)
- **Cash and equivalents:** $36.5M (USD 36,455,000)
- **Operating cash flow:** -$43.1M (USD -43,150,000)

## Recent SEC filings

- Form 8-K — filed 2023-09-25 — period 2023-09-25 — 8-K
- Form 8-K — filed 2023-08-25 — period 2023-08-25 — 8-K
- Form SC 13D — filed 2023-08-18 — SC 13D
- Form 10-Q — filed 2023-08-11 — period 2023-06-30 — 10-Q
- Form 8-K — filed 2023-08-09 — period 2023-08-08 — 8-K
- Form 8-K — filed 2023-06-13 — period 2023-06-13 — 8-K
- Form 10-Q — filed 2023-05-15 — period 2023-03-31 — 10-Q
- Form DEF 14A — filed 2023-04-28 — period 2023-06-13 — DEF 14A
- Form 8-K — filed 2023-04-06 — period 2023-04-04 — 8-K
- Form 8-K — filed 2023-03-21 — period 2023-03-19 — 8-K
- Form 10-K — filed 2023-03-14 — period 2022-12-31 — 10-K
- Form 8-K — filed 2023-03-13 — period 2023-03-10 — 8-K

---

Updated: 2026-10-23T20:12:17Z

Canonical page: https://altss.com/profile/decibel-therapeutics-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology